SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-371080
Filing Date
2015-11-09
Accepted
2015-11-09 07:51:31
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d94494d10q.htm 10-Q 224843
2 EX-31.1 d94494dex311.htm EX-31.1 8740
3 EX-31.2 d94494dex312.htm EX-31.2 8741
4 EX-32.1 d94494dex321.htm EX-32.1 4387
5 EX-32.2 d94494dex322.htm EX-32.2 4423
  Complete submission text file 0001193125-15-371080.txt   1977885

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT galt-20150930.xml EX-101.INS 236723
7 XBRL TAXONOMY EXTENSION SCHEMA galt-20150930.xsd EX-101.SCH 30398
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE galt-20150930_cal.xml EX-101.CAL 34181
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE galt-20150930_def.xml EX-101.DEF 174516
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20150930_lab.xml EX-101.LAB 240838
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20150930_pre.xml EX-101.PRE 206626
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31791 | Film No.: 151214003
SIC: 2834 Pharmaceutical Preparations